Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment
Clinical trial NCT01285401 · COMPLETED
Trial details
- NCT number
- NCT01285401
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2015-04-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.